Regional Analysis of the Tremfya Market
The rising burden of chronic inflammatory and autoimmune disorders has significantly increased demand for targeted biologic therapies. Among these, Tremfya (guselkumab) has emerged as a leading treatment option for moderate-to-severe plaque psoriasis and psoriatic arthritis. Strong Tremfya drug market growth, expanding guselkumab market applications, and increasing demand within...
0 التعليقات 0 المشاركات 4 مشاهدة 0 معاينة
AC Mingle https://acmingle.com